SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000920465-19-000044
Filing Date
2019-03-04
Accepted
2019-03-04 16:11:05
Documents
65
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ljpc-201810xk.htm 10-K 1239515
2 EXHIBIT 21.1 exhibit211fy2018.htm EX-21.1 6452
3 EXHIBIT 23.1 exhibit231fy2018.htm EX-23.1 4075
4 EXHIBIT 31.1 exhibit311fy201810-k.htm EX-31.1 14736
5 EXHIBIT 31.2 exhibit312fy201810-k.htm EX-31.2 14671
6 EXHIBIT 32.1 exhibit321fy201810-k.htm EX-32.1 12297
  Complete submission text file 0000920465-19-000044.txt   5510084

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ljpc-20181231.xml EX-101.INS 865660
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20181231.xsd EX-101.SCH 41029
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20181231_cal.xml EX-101.CAL 73372
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20181231_def.xml EX-101.DEF 237160
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20181231_lab.xml EX-101.LAB 647668
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20181231_pre.xml EX-101.PRE 360216
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36282 | Film No.: 19653833
SIC: 2836 Biological Products, (No Diagnostic Substances)